Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity (Details Narrative)

v3.22.1
Shareholders Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Mar. 10, 2021
Apr. 30, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Aug. 01, 2020
Subsidiary, Sale of Stock [Line Items]            
Common stock, shares authorized     500,000,000   500,000,000  
Preferred stock, shares authorized     50,000,000   50,000,000  
Number of shares issued to common stock 30,000          
Stock compensation expense related to stock options, unrecognized     $ 470,685 $ 417,462    
Number of shares issued to acquisitions       159,437    
Number of stock granted     237,500      
Restricted stock expense     $ 368,162      
Weighted-average period     2 years 9 months 8 months 26 days    
Number of options granted     522,462      
Exercise price     $ 1.26      
Stock options term     8 years      
Fair value of the stock options     $ 0   $ 0  
Intrinsic value of options and warrants outstanding     0   $ 0  
Underwriter [Member]            
Subsidiary, Sale of Stock [Line Items]            
Warrants exercisable date   Sep. 14, 2024        
Exercise price per share   $ 5.00        
Lender [Member]            
Subsidiary, Sale of Stock [Line Items]            
Number of shares issued to common stock 10,000          
Number of warrants issued   106,291        
Restricted Stock Forfeitures [Member]            
Subsidiary, Sale of Stock [Line Items]            
Stock compensation expense related to stock options, unrecognized     $ 1,221      
Restricted Stock [Member]            
Subsidiary, Sale of Stock [Line Items]            
Stock compensation expense related to stock options, unrecognized       $ 709,000    
Unrecognized Stock [Member]            
Subsidiary, Sale of Stock [Line Items]            
Stock compensation expense related to stock options, unrecognized       $ 243,000    
Executives and Other Employees [Member]            
Subsidiary, Sale of Stock [Line Items]            
Number of shares issued to common stock       54,474    
Stock compensation expense related to stock options, unrecognized       $ 205,000    
Sponsorship [Member]            
Subsidiary, Sale of Stock [Line Items]            
Number of shares issued to common stock       16,807    
Consulting Services [Member]            
Subsidiary, Sale of Stock [Line Items]            
Number of shares issued to common stock       26,573    
Stock issued for sevices     10,000      
Sponsorship and Consulting Services [Member]            
Subsidiary, Sale of Stock [Line Items]            
Stock compensation expense related to stock options, unrecognized       $ 163,249    
Seller of Assets for Service Fueling [Member]            
Subsidiary, Sale of Stock [Line Items]            
Stock issued for sevices     40,323      
Black Scholes [Member]            
Subsidiary, Sale of Stock [Line Items]            
Fair value of the stock options     $ 350,000      
2020 Equity Incentive Plan [Member]            
Subsidiary, Sale of Stock [Line Items]            
Number of shares reserved           1,913,243
IPO [Member]            
Subsidiary, Sale of Stock [Line Items]            
Stock Issued during period, shares, conversion of convertible securities     18,750,000      
Stockholders' equity, reverse stock split     one for 3.763243 reverse stock split approved by the Company’s board of directors and its shareholders      
IPO [Member] | Underwriter [Member]            
Subsidiary, Sale of Stock [Line Items]            
Warrant to purchase common stock     359,375      
Warrants exercisable date     Mar. 14, 2022      
Warrants exercisable date     Sep. 14, 2026      
Exercise price per share     $ 5.00